Covered recipient · General Payments record
ERIN L ARNOLD
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$37,017.88
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,140.00 | 2 |
| Travel and Lodging | $1,427.50 | 5 |
| Food and Beverage | $860.67 | 24 |
| Education | $19.25 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $7,552.75 | 16 |
| Janssen Biotech, Inc. | $2,398.26 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $183.53 | 5 |
| GENZYME CORPORATION | $132.45 | 1 |
| Janssen Scientific Affairs, LLC | $85.06 | 1 |
| Genentech USA, Inc. | $46.18 | 2 |
| ABBVIE INC. | $29.94 | 1 |
| SOBI, INC | $19.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.94 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103240677 | CMS |
| Genentech USA, Inc. | $23.56 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133009096 | CMS |
| Genentech USA, Inc. | $22.62 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133009100 | CMS |
| GENZYME CORPORATION | $132.45 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139698206 | CMS |
| Janssen Biotech, Inc. | $130.79 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078605176 | CMS |
| Janssen Biotech, Inc. | $47.25 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078605459 | CMS |
| Janssen Biotech, Inc. | $2,160.00 | 08/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078605283 | CMS |
| Janssen Biotech, Inc. | $28.10 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078605587 | CMS |
| Janssen Biotech, Inc. | $32.12 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078605446 | CMS |
| Janssen Scientific Affairs, LLC | $85.06 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078850175 | CMS |
| Novartis Pharmaceuticals Corporation | $38.68 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086670469 | CMS |
| Novartis Pharmaceuticals Corporation | $62.50 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086670473 | CMS |
| Novartis Pharmaceuticals Corporation | $23.37 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086670475 | CMS |
| Novartis Pharmaceuticals Corporation | $35.51 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086670477 | CMS |
| Novartis Pharmaceuticals Corporation | $23.47 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086670479 | CMS |
| SOBI, INC | $19.25 | 05/02/2024 | Education | Undisputed | 01/23/2026 | 1141438535 | CMS |
| UCB, Inc. | $7.13 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143200064 | CMS |
| UCB, Inc. | $75.36 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143200066 | CMS |
| UCB, Inc. | $7.79 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143200068 | CMS |
| UCB, Inc. | $9.00 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143200071 | CMS |
| UCB, Inc. | $60.00 | 05/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143200075 | CMS |
| UCB, Inc. | $180.38 | 05/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143200080 | CMS |
| UCB, Inc. | $314.64 | 05/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143200084 | CMS |
| UCB, Inc. | $556.95 | 05/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143200088 | CMS |
| UCB, Inc. | $315.53 | 05/24/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143200093 | CMS |
| UCB, Inc. | $8.02 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143200097 | CMS |
| UCB, Inc. | $5,980.00 | 07/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143226768 | CMS |
| UCB, Inc. | $7.85 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143226772 | CMS |
| UCB, Inc. | $6.40 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143226776 | CMS |
| UCB, Inc. | $9.05 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143226781 | CMS |
| UCB, Inc. | $7.19 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143226785 | CMS |
| UCB, Inc. | $7.46 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143226789 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.